Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32 | 105649 | 40.4 | 80% |
Classes in level above (level 4) |
Classes in level below (level 2) |
| ID, lev. below |
Publications | Label for level below |
|---|---|---|
| 26 | 34435 | ANTIRETROVIRAL THERAPY//HIV//NEVIRAPINE |
| 40 | 31853 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
| 234 | 19638 | APOBEC3G//INTEGRASE//HIV 1 INTEGRASE |
| 1341 | 7881 | HTLV I//HTLV 1//HAM TSP |
| 1825 | 5671 | HUMAN ENDOGENOUS RETROVIRUS//ADAR//ENDOGENOUS RETROVIRUS |
| 2355 | 3924 | FELINE IMMUNODEFICIENCY VIRUS//CAPRINE ARTHRITIS ENCEPHALITIS VIRUS//FIV |
| 2929 | 2247 | HIV 1 PROTEASE//HIV PROTEASE//KNI 272 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VIROLOGY | WoS category | 6115 | 19% | 28% | 29799 |
| 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES | Journal | 5225 | 75% | 4% | 3802 |
| 3 | HIV 1 | Author keyword | 4938 | 63% | 5% | 4954 |
| 4 | HIV | Author keyword | 3156 | 30% | 9% | 8984 |
| 5 | AIDS | Journal | 2365 | 47% | 4% | 3765 |
| 6 | JOURNAL OF VIROLOGY | Journal | 2079 | 22% | 8% | 8334 |
| 7 | ANTIRETROVIRAL THERAPY | Author keyword | 1985 | 56% | 2% | 2388 |
| 8 | RETROVIROLOGY | Journal | 1416 | 80% | 1% | 881 |
| 9 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Journal | 1032 | 45% | 2% | 1710 |
| 10 | HTLV I | Author keyword | 803 | 79% | 0% | 516 |
Web of Science journal categories |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | Virology | 6115 | 19% | 28% | 29799 |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HIV 1 | 4938 | 63% | 5% | 4954 | Search HIV+1 | Search HIV+1 |
| 2 | HIV | 3156 | 30% | 9% | 8984 | Search HIV | Search HIV |
| 3 | ANTIRETROVIRAL THERAPY | 1985 | 56% | 2% | 2388 | Search ANTIRETROVIRAL+THERAPY | Search ANTIRETROVIRAL+THERAPY |
| 4 | AIDS | 1101 | 28% | 3% | 3412 | Search AIDS | Search AIDS |
| 5 | HTLV I | 803 | 79% | 0% | 516 | Search HTLV+I | Search HTLV+I |
| 6 | HTLV 1 | 712 | 73% | 1% | 538 | Search HTLV+1 | Search HTLV+1 |
| 7 | ZIDOVUDINE | 687 | 65% | 1% | 660 | Search ZIDOVUDINE | Search ZIDOVUDINE |
| 8 | NEVIRAPINE | 644 | 76% | 0% | 453 | Search NEVIRAPINE | Search NEVIRAPINE |
| 9 | RETROVIRUS | 579 | 47% | 1% | 906 | Search RETROVIRUS | Search RETROVIRUS |
| 10 | HAART | 577 | 47% | 1% | 913 | Search HAART | Search HAART |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMMUNODEFICIENCY VIRUS TYPE 1 | 8593 | 62% | 8% | 8965 |
| 2 | HUMAN IMMUNODEFICIENCY VIRUS | 6829 | 35% | 15% | 16000 |
| 3 | ANTIRETROVIRAL THERAPY | 2610 | 40% | 5% | 5058 |
| 4 | HIV 1 INFECTION | 2381 | 54% | 3% | 3036 |
| 5 | ZIDOVUDINE | 2337 | 61% | 2% | 2475 |
| 6 | TROPICAL SPASTIC PARAPARESIS | 2332 | 90% | 1% | 1014 |
| 7 | MURINE LEUKEMIA VIRUS | 2142 | 67% | 2% | 1956 |
| 8 | ACTIVE ANTIRETROVIRAL THERAPY | 2034 | 38% | 4% | 4234 |
| 9 | HTLV I | 2012 | 75% | 1% | 1456 |
| 10 | VIRUS TYPE I | 1952 | 74% | 1% | 1441 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 5225 | 75% | 4% | 3802 |
| 2 | AIDS | 2365 | 47% | 4% | 3765 |
| 3 | JOURNAL OF VIROLOGY | 2079 | 22% | 8% | 8334 |
| 4 | RETROVIROLOGY | 1416 | 80% | 1% | 881 |
| 5 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1032 | 45% | 2% | 1710 |
| 6 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 644 | 52% | 1% | 870 |
| 7 | VIROLOGY | 522 | 16% | 3% | 2920 |
| 8 | ANTIVIRAL THERAPY | 394 | 41% | 1% | 737 |
| 9 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 375 | 52% | 0% | 517 |
| 10 | CURRENT HIV RESEARCH | 349 | 56% | 0% | 425 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel | 2012 | 409 | 116 | 52% |
| Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy | 2014 | 49 | 149 | 91% |
| Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel | 2014 | 50 | 130 | 77% |
| The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection | 2011 | 426 | 68 | 57% |
| Initial sequencing and analysis of the human genome | 2001 | 10496 | 369 | 11% |
| Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease | 1999 | 1468 | 212 | 87% |
| Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review | 2011 | 220 | 26 | 96% |
| SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | 2012 | 190 | 46 | 74% |
| The impact of retrotransposons on human genome evolution | 2009 | 388 | 156 | 85% |
| Insights into the trimeric HIV-1 envelope glycoprotein structure | 2015 | 4 | 58 | 95% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AIDS | 1353 | 47% | 2.0% | 2114 |
| 2 | HIV DRUG ISTANCE PROGRAM | 788 | 82% | 0.4% | 467 |
| 3 | RETROVIRUS | 549 | 68% | 0.5% | 486 |
| 4 | RETROVIROL | 450 | 60% | 0.5% | 496 |
| 5 | VIROL | 442 | 12% | 3.3% | 3527 |
| 6 | AARON DIAMOND AIDS | 312 | 63% | 0.3% | 311 |
| 7 | HUMAN RETROVIROL | 283 | 60% | 0.3% | 311 |
| 8 | PARTNERS AIDS | 251 | 62% | 0.2% | 258 |
| 9 | VACCINE | 203 | 28% | 0.6% | 614 |
| 10 | MCGILL AIDS | 201 | 77% | 0.1% | 137 |
Related classes at same level (level 3) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000006625 | LIPODYSTROPHY//PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII |
| 2 | 0.0000003095 | SEXUALLY TRANSMITTED DISEASES//SEXUALLY TRANSMITTED INFECTIONS//AIDS AND BEHAVIOR |
| 3 | 0.0000001770 | GENOME EDITING//CAS9//CRISPR |
| 4 | 0.0000001411 | ORTHOPOXVIRUS//POXVIRUS//VACCINIA VIRUS |
| 5 | 0.0000001280 | JOURNAL OF IMMUNOLOGY//IMMUNOL//DENDRITIC CELLS |
| 6 | 0.0000001259 | VIROLOGY//CYTOMEGALOVIRUS//EPSTEIN BARR VIRUS |
| 7 | 0.0000001239 | HEPATITIS C VIRUS//HEPATITIS B VIRUS//HEPATITIS C |
| 8 | 0.0000001234 | GENE DELIVERY//GENE THERAPY//ANTIMICROBIAL PEPTIDE |
| 9 | 0.0000001224 | TISSUE ANTIGENS//ANKYLOSING SPONDYLITIS//IMMUNOGENETICS |
| 10 | 0.0000001122 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//CATALYTIC ANTIBODY |